These facts comprehensively demonstrate that while performing its own function of suppressing super - enhancers, BRD4 inhibitors can enhance the anti - tumor function of PARP1 inhibitors, compensating for the deficiency of single - target inhibitors in being prone to drug resistance, and thus possess broad development prospects. The gene discussed is BRD4; the disease is neoplasm.